Page 1

2 Humana Interim report , Jan - Jun , Q2 2021 A stable second quarter Second quarter , April - June 2021 Operating revenue was SEK 2,058m ( 1,980 ) , an increase of 4.0 percent . Organic growth was 3.4 percent . Operating profit amounted to SEK 107m ( 100 ) , an increase of 6.6 percent . Capital gain on sale of properties of SEK 17m is included in the comparison period . Adjusted operating profit was SEK 107m ( 83 ) , an increase of 28.4 percent . Net profit after tax for the period amounted to SEK 57m ( 50 ) . Basic and diluted earnings per share for the period amounted to SEK 1.18 ( 0.94 ) . Operating cash flow amounted to SEK 251m ( 221 ) . Six - month period , January - June 2021 Operating revenue was SEK 4,044m ( 3,918 ) , an increase of 3.2 percent . Organic growth was 2.9 percent . . Operating profit amounted to SEK 219m ( 198 ) , an increase of 10.6 percent . Capital gain on sale of properties of SEK 17m is included in the comparison period . Adjusted operating profit was SEK 219m ( 181 ) , an increase of 21 percent . Net profit after tax for the period amounted to SEK 120m ( 103 ) . Basic and diluted earnings per share for the period amounted to SEK 2.45 ( 1.94 ) . Operating cash flow amounted to SEK 448m ( 317 ) . Significant events in and after the end of the quarter During the quarter , Humana signed a contract to acquire all shares in individual and family company alans Behandling AB . The ansfer of the operation will occur in the fourth quarter of 2021. The business , with head office in Luleå , will then be part of Humana's Individual & Family business area . The company's annual revenue is approximately SEK 60m and it has around 20 employees . After the end of the quarter , Humana entered a new financing agreement with four banks - SEB , DNB , Swedbank and Svensk Exportkredit for SEK 3bn with an option for an additional SEK 1bn . The new agreement has a three - year term with two extension options of one year each . Humana's President and CEO Rasmus Nerman has , on August 11 , informed the Board that he will leave the company , as he has accepted the role of President and CEO of Apoteket AB . The Board has started the process of recruiting his successor . Key ratios SEK millions Net revenue Other operating revenue Operating revenue Operating profit Adjusted operating profit Net profit for the period Operating cash flow Apr - Jun Apr - Jun 2021 2020 2,058 1,962 0 2,058 107 107 57 251 Jul - Jun Jan - Dec % 2020/21 2020 5 % 4,042 3,894 4 % 7,919 % 18 -100 % 1,980 4 % 100 7 % 83 28 % 221 50 14 % 14 % Jan - Jun Jan - Jun 2021 2020 2 24 -91 % 4,044 3,918 3 % 219 198 11 % 219 120 448 181 21 % 103 16 % 317 41 % 492 % 7,771 2 % 4 26 -84 % 7,923 7,797 2 % 492 471 4 % 453 8 % 280 911 779 262 6 % 17 % Interim report , Jan - Jun , Q2 2021 | 1